{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:47:46Z","timestamp":1785883666402,"version":"3.56.0"},"reference-count":24,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1111\/all.12920","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T07:45:50Z","timestamp":1461051950000},"page":"1585-1593","source":"Crossref","is-referenced-by-count":55,"title":["Patient-reported disease-specific quality-of-life and symptom severity in systemic mastocytosis"],"prefix":"10.1111","volume":"71","author":[{"given":"B.","family":"van Anrooij","sequence":"first","affiliation":[{"name":"Department of Allergology; University of Groningen; University Medical Center Groningen; Groningen The Netherlands"},{"name":"University of Groningen; University Medical Center Groningen; GRIAC Research Institute; Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Kluin-Nelemans","sequence":"additional","affiliation":[{"name":"Department of Hematology; University of Groningen; University Medical Center Groningen; Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Safy","sequence":"additional","affiliation":[{"name":"Department of Allergology; University of Groningen; University Medical Center Groningen; Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M. J.","family":"Flokstra-de Blok","sequence":"additional","affiliation":[{"name":"University of Groningen; University Medical Center Groningen; GRIAC Research Institute; Groningen The Netherlands"},{"name":"Department of General Practice; University of Groningen; University Medical Center Groningen; Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. N. G.","family":"Oude Elberink","sequence":"additional","affiliation":[{"name":"Department of Allergology; University of Groningen; University Medical Center Groningen; Groningen The Netherlands"},{"name":"University of Groningen; University Medical Center Groningen; GRIAC Research Institute; Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,23]]},"reference":[{"key":"10.1111\/all.12920-BIB0001|all12920-cit-0001","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000048188","article-title":"Mastocytosis: mediator-related signs and symptoms","volume":"127","author":"Castells","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/all.12920-BIB0002|all12920-cit-0002","first-page":"54","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Horny","year":"2008"},{"key":"10.1111\/all.12920-BIB0003|all12920-cit-0003","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOH.0b013e3283366c59","article-title":"Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 mayo clinic patients and current literature","volume":"17","author":"Pardanani","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/all.12920-BIB0004|all12920-cit-0004","doi-asserted-by":"crossref","first-page":"e2266","DOI":"10.1371\/journal.pone.0002266","article-title":"Case-control cohort study of patients\u2019 perceptions of disability in mastocytosis","volume":"3","author":"Hermine","year":"2008","journal-title":"PLoS One"},{"key":"10.1111\/all.12920-BIB0005|all12920-cit-0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000329218","article-title":"Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience","volume":"157","author":"Wimazal","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/all.12920-BIB0006|all12920-cit-0006","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features vs other indolent SM","volume":"133","author":"Alvarez-Twose","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12920-BIB0007|all12920-cit-0007","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.12225","article-title":"High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience","volume":"44","author":"Gulen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.12920-BIB0008|all12920-cit-0008","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/all.12920-BIB0009|all12920-cit-0009","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0609.2010.01407.x","article-title":"A critical reappraisal of treatment response criteria in systemic mastocytosis and a proposal for revisions","volume":"84","author":"Pardanani","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1111\/all.12920-BIB0010|all12920-cit-0010","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/bjh.12265","article-title":"Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study","volume":"161","author":"Gruson","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1111\/all.12920-BIB0011|all12920-cit-0011","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/all.12159","article-title":"Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial","volume":"68","author":"Siebenhaar","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12920-BIB0012|all12920-cit-0012","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1398-9995.2009.02304.x","article-title":"Health-related quality of life of food allergic patients measured with generic and disease-specific questionnaires","volume":"65","author":"Flokstra-de Blok","year":"2010","journal-title":"Allergy"},{"key":"10.1111\/all.12920-BIB0013|all12920-cit-0013","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaip.2013.09.004","article-title":"The mastocytosis society survey on mast cell disorders: patient experiences and perceptions","volume":"2","author":"Jennings","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1111\/all.12920-BIB0014|all12920-cit-0014","first-page":"49","volume-title":"Quality of Life and Pharmacoeconomics in Clinical Trials","author":"Juniper","year":"1996"},{"key":"10.1111\/all.12920-BIB0015|all12920-cit-0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0091-6749(94)90349-2","article-title":"Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials","volume":"93","author":"Juniper","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12920-BIB0016|all12920-cit-0016","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/thx.47.2.76","article-title":"Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials","volume":"47","author":"Juniper","year":"1992","journal-title":"Thorax"},{"key":"10.1111\/all.12920-BIB0017|all12920-cit-0017","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.leukres.2009.01.035","article-title":"The myelofibrosis symptom assessment form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis","volume":"33","author":"Mesa","year":"2009","journal-title":"Leuk Res"},{"key":"10.1111\/all.12920-BIB0018|all12920-cit-0018","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/07853890109002089","article-title":"The RAND-36 measure of health-related quality of life","volume":"33","author":"Hays","year":"2001","journal-title":"Ann Med"},{"key":"10.1111\/all.12920-BIB0019|all12920-cit-0019","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0009-8981(82)90247-9","article-title":"Determination of N tau-methylimidazoleacetic acid (a histamine metabolite) in urine by gas chromatography using nitrogen-phosphorus detection","volume":"121","author":"Keyzer","year":"1982","journal-title":"Clin Chim Acta"},{"key":"10.1111\/all.12920-BIB0020|all12920-cit-0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01993171","article-title":"Measurement of urinary N tau-methylhistamine excretion: correlation of a newly developed radioimmunoassay (RIA) with gas chromatography mass spectrometry (GCMS)","volume":"33","author":"Oosting","year":"1991","journal-title":"Agents Actions"},{"key":"10.1111\/all.12920-BIB0021|all12920-cit-0021","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/02770906609106941","article-title":"Diagnosis and treatment of insect sensitivity","volume":"3","author":"Mueller","year":"1966","journal-title":"J Asthma Res"},{"key":"10.1111\/all.12920-BIB0022|all12920-cit-0022","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.annemergmed.2006.01.018","article-title":"Second symposium on the definition and management of anaphylaxis: summary report-second national institute of allergy and infectious Disease\/Food allergy and anaphylaxis network symposium","volume":"47","author":"Sampson","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1111\/all.12920-BIB0023|all12920-cit-0023","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in spain: a study of the spanish network on mastocytosis (REMA)","volume":"37","author":"Gonzalez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.12920-BIB0024|all12920-cit-0024","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaci.2012.12.1578","article-title":"Higher mast cell load decreases the risk of hymenoptera venom-induced anaphylaxis in patients with mastocytosis","volume":"132","author":"Anrooij","year":"2013","journal-title":"J Allergy Clin Immunol"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fall.12920","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T21:01:31Z","timestamp":1718485291000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/all.12920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,23]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"URL":"https:\/\/doi.org\/10.1111\/all.12920","archive":["Portico"],"relation":{},"ISSN":["0105-4538"],"issn-type":[{"value":"0105-4538","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6,23]]}}}